2012·Masters·University of Zambia
The production of substandard and counterfeit drugs as a result of non-adherence to good manufacturing practices by pharmaceutical companies is a vast and underreported worldwide problem particularly affecting developing countries. Developing countries are not only markets for substandard and...
Download PDF ↓